Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Teva
Merck
Julphar
Daiichi Sankyo
Farmers Insurance
McKesson
Cantor Fitzgerald

Generated: August 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086413

« Back to Dashboard

NDA 086413 describes TRIAMCINOLONE ACETONIDE, which is a drug marketed by Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Fougera Pharms, G And W Labs, Glenmark Pharms Ltd, Lannett Co Inc, Lupin Atlantis, Macleods Pharms Ltd, Morton Grove, Mylan Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Taro Pharm Inds Ltd, Teligent Pharma Inc, Topiderm, Amneal Pharms Co, Parnell, Sandoz Inc, Watson Labs, Akorn, G And W Labs Inc, Wockhardt Bio Ag, Glenmark Pharms, Lyne, Perrigo Israel, Perrigo Uk Finco, Riconpharma Llc, and Cmp Pharma Inc, and is included in seventy-seven NDAs. It is available from sixty-five suppliers. Additional details are available on the TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 086413
Tradename:TRIAMCINOLONE ACETONIDE
Applicant:Perrigo New York
Ingredient:triamcinolone acetonide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 086413
Medical Subject Heading (MeSH) Categories for 086413
Suppliers and Packaging for NDA: 086413
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 086413 ANDA Perrigo New York Inc 45802-063 N 45802-063-05
TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 086413 ANDA Perrigo New York Inc 45802-063 N 45802-063-35

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Teva
Johnson and Johnson
US Army
McKesson
Deloitte
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.